195 related articles for article (PubMed ID: 33472091)
1. Prolactin synergizes with canonical Wnt signals to drive development of ER+ mammary tumors via activation of the Notch pathway.
O'Leary KA; Rugowski DE; Shea MP; Sullivan R; Moser AR; Schuler LA
Cancer Lett; 2021 Apr; 503():231-239. PubMed ID: 33472091
[TBL] [Abstract][Full Text] [Related]
2. Tissue-dependent consequences of Apc inactivation on proliferation and differentiation of ciliated cell progenitors via Wnt and notch signaling.
Li A; Chan B; Felix JC; Xing Y; Li M; Brody SL; Borok Z; Li C; Minoo P
PLoS One; 2013; 8(4):e62215. PubMed ID: 23646120
[TBL] [Abstract][Full Text] [Related]
3. Prolactin promotes mammary pathogenesis independently from cyclin D1.
Asher JM; O'Leary KA; Rugowski DE; Arendt LM; Schuler LA
Am J Pathol; 2012 Jul; 181(1):294-302. PubMed ID: 22658484
[TBL] [Abstract][Full Text] [Related]
4. Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.
O'Leary KA; Shea MP; Schuler LA
Adv Exp Med Biol; 2015; 846():201-20. PubMed ID: 25472540
[TBL] [Abstract][Full Text] [Related]
5. A knock-in mouse model reveals roles for nuclear Apc in cell proliferation, Wnt signal inhibition and tumor suppression.
Zeineldin M; Cunningham J; McGuinness W; Alltizer P; Cowley B; Blanchat B; Xu W; Pinson D; Neufeld KL
Oncogene; 2012 May; 31(19):2423-37. PubMed ID: 21996741
[TBL] [Abstract][Full Text] [Related]
6. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer.
Rodilla V; Villanueva A; Obrador-Hevia A; Robert-Moreno A; Fernández-Majada V; Grilli A; López-Bigas N; Bellora N; Albà MM; Torres F; Duñach M; Sanjuan X; Gonzalez S; Gridley T; Capella G; Bigas A; Espinosa L
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6315-20. PubMed ID: 19325125
[TBL] [Abstract][Full Text] [Related]
7. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R
PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404
[TBL] [Abstract][Full Text] [Related]
8. Prolactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males.
Arendt LM; Schuler LA
Am J Pathol; 2008 Jan; 172(1):194-202. PubMed ID: 18156207
[TBL] [Abstract][Full Text] [Related]
9. Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth.
Vomachka AJ; Pratt SL; Lockefeer JA; Horseman ND
Oncogene; 2000 Feb; 19(8):1077-84. PubMed ID: 10713693
[TBL] [Abstract][Full Text] [Related]
10. Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes.
Arendt LM; Evans LC; Rugowski DE; Garcia-Barchino MJ; Rui H; Schuler LA
J Endocrinol; 2009 Oct; 203(1):99-110. PubMed ID: 19635758
[TBL] [Abstract][Full Text] [Related]
11. The APC tumor suppressor is required for epithelial integrity in the mouse mammary gland.
Prosperi JR; Becher KR; Willson TA; Collins MH; Witte DP; Goss KH
J Cell Physiol; 2009 Aug; 220(2):319-31. PubMed ID: 19326388
[TBL] [Abstract][Full Text] [Related]
12. Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer.
Arendt LM; Rugowski DE; Grafwallner-Huseth TA; Garcia-Barchino MJ; Rui H; Schuler LA
Breast Cancer Res; 2011 Jan; 13(1):R11. PubMed ID: 21276249
[TBL] [Abstract][Full Text] [Related]
13. Induction of endoplasmic reticulum stress by deletion of Grp78 depletes Apc mutant intestinal epithelial stem cells.
van Lidth de Jeude JF; Meijer BJ; Wielenga MCB; Spaan CN; Baan B; Rosekrans SL; Meisner S; Shen YH; Lee AS; Paton JC; Paton AW; Muncan V; van den Brink GR; Heijmans J
Oncogene; 2017 Jun; 36(24):3397-3405. PubMed ID: 27819675
[TBL] [Abstract][Full Text] [Related]
14. Prolactin cooperates with loss of p53 to promote claudin-low mammary carcinomas.
O'Leary KA; Rugowski DE; Sullivan R; Schuler LA
Oncogene; 2014 Jun; 33(23):3075-82. PubMed ID: 23873024
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency.
Gallagher RC; Hay T; Meniel V; Naughton C; Anderson TJ; Shibata H; Ito M; Clevers H; Noda T; Sansom OJ; Mason JO; Clarke AR
Oncogene; 2002 Sep; 21(42):6446-57. PubMed ID: 12226748
[TBL] [Abstract][Full Text] [Related]
16. Apc mutation enhances PyMT-induced mammary tumorigenesis.
Prosperi JR; Khramtsov AI; Khramtsova GF; Goss KH
PLoS One; 2011; 6(12):e29339. PubMed ID: 22216254
[TBL] [Abstract][Full Text] [Related]
17. Functional redundancy between Apc and Apc2 regulates tissue homeostasis and prevents tumorigenesis in murine mammary epithelium.
Daly CS; Shaw P; Ordonez LD; Williams GT; Quist J; Grigoriadis A; Van Es JH; Clevers H; Clarke AR; Reed KR
Oncogene; 2017 Mar; 36(13):1793-1803. PubMed ID: 27694902
[TBL] [Abstract][Full Text] [Related]
18. Prolactin Alters the Mammary Epithelial Hierarchy, Increasing Progenitors and Facilitating Ovarian Steroid Action.
O'Leary KA; Shea MP; Salituro S; Blohm CE; Schuler LA
Stem Cell Reports; 2017 Oct; 9(4):1167-1179. PubMed ID: 28919264
[TBL] [Abstract][Full Text] [Related]
19. Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis.
Moumen M; Chiche A; Decraene C; Petit V; Gandarillas A; Deugnier MA; Glukhova MA; Faraldo MM
Mol Cancer; 2013 Oct; 12(1):132. PubMed ID: 24171719
[TBL] [Abstract][Full Text] [Related]
20. Development of gastric tumors in Apc(Min/+) mice by the activation of the beta-catenin/Tcf signaling pathway.
Tomita H; Yamada Y; Oyama T; Hata K; Hirose Y; Hara A; Kunisada T; Sugiyama Y; Adachi Y; Linhart H; Mori H
Cancer Res; 2007 May; 67(9):4079-87. PubMed ID: 17483318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
